The College of Optometrists has published a new online course for members to enhance their clinical expertise in myopia management.

The Medicine & Healthcare products Regulatory Agency (MHRA) has approved the first licensed low-dose atropine (LDA) treatment for slowing the progression of childhood myopia.

This article explains the current understanding of the risk factors, diagnosis, limitations and management of glaucoma in myopes.